Histopathology and levels of proteins in plasma associate with survival after colorectal cancer diagnosis

• Published in: British journal of cancer Vol. 129; no. 7; pp. 1142 - 1151
• Main Authors: Magnusson, Magnus I., Agnarsson, Bjarni A., Jonasson, Jon G., Tryggvason, Thordur, Aeffner, Famke, le Roux, Louise, Magnusdottir, Droplaug N., Gunnarsdottir, Helga S., Alexíusdóttir, Kristín K., Gunnarsdottir, Kristbjorg, Söebech, Emilia, Runarsdottir, Hjaltey, Jonsdottir, Erna M., Kristinsdottir, Bjarney S., Olafsson, Sigurgeir, Knutsdottir, Hildur, Thorsteinsdottir, Unnur, Ulfarsson, Magnus O., Gudbjartsson, Daniel F., Saemundsdottir, Jona, Magnusson, Olafur T., Norddahl, Gudmundur L., Watson, J. E. Vivienne, Rafnar, Thorunn, Lund, Sigrun H., Stefansson, Kari
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 19.10.2023; Nature Publishing Group
• Subjects: 631/67/1504/1885; 631/67/1857; Biomedical and Life Sciences; Biomedicine; Cancer Research; Colorectal cancer; Colorectal carcinoma; Diagnosis; Drug Resistance; Epidemiology; Follicles; Histopathology; Infiltration; Medical diagnosis; Medical prognosis; Metastases; Microsatellite instability; Molecular Medicine; Multivariate analysis; Mutation; Oncology; p53 Protein; Plasma proteins; Prognosis; Proteins; Stroma; Survival; Tumors
• ISSN: 0007-0920; 1532-1827
• DOI: 10.1038/s41416-023-02374-z

Background The TNM system is used to assess prognosis after colorectal cancer (CRC) diagnosis. Other prognostic factors reported include histopathological assessments of the tumour, tumour mutations and proteins in the blood. As some of these factors are strongly correlated, it is important to evaluate the independent effects they may have on survival. Methods Tumour samples from 2162 CRC patients were visually assessed for amount of tumour stroma, severity of lymphocytic infiltrate at the tumour margins and the presence of lymphoid follicles. Somatic mutations in the tumour were assessed for 2134 individuals. Pre-surgical levels of 4963 plasma proteins were measured in 128 individuals. The associations between these features and prognosis were inspected by a Cox Proportional Hazards Model (CPH). Results Levels of stroma, lymphocytic infiltration and presence of lymphoid follicles all associate with prognosis, along with high tumour mutation burden, high microsatellite instability and TP53 and BRAF mutations. The somatic mutations are correlated with the histopathology and none of the somatic mutations associate with survival in a multivariate analysis. Amount of stroma and lymphocytic infiltration associate with local invasion of tumours. Elevated levels of two plasma proteins, CA-125 and PPP1R1A, associate with a worse prognosis. Conclusions Tumour stroma and lymphocytic infiltration variables are strongly associated with prognosis of CRC and capture the prognostic effects of tumour mutation status. CA-125 and PPP1R1A may be useful prognostic biomarkers in CRC.